Induction of CD4$^+$ Human Cytolytic T Cells Specific for HIV-Infected Cells by a gp160 Subunit Vaccine

Cytolytic T lymphocyte (CTL) responses were evaluated in humans immunized with recombinant human immunodeficiency virus type 1 (HIV) envelope glycoprotein gp160. Some vaccinees had gp160-specific CTLs that were shown by cloning to be CD4$^+$. Although induced by exogenous antigen, most gp160-specifi...

Full description

Saved in:
Bibliographic Details
Published inScience (American Association for the Advancement of Science) Vol. 248; no. 4960; pp. 1234 - 1237
Main Authors Orentas, Rimas J., James E. K. Hildreth, Obah, Eugene, Polydefkis, Michael, Smith, Gale E., Clements, Mary Lou, Siliciano, Robert F.
Format Journal Article
LanguageEnglish
Published Washington, DC American Society for the Advancement of Science 08.06.1990
American Association for the Advancement of Science
The American Association for the Advancement of Science
Subjects
Online AccessGet full text
ISSN0036-8075
1095-9203
DOI10.1126/science.2190315

Cover

More Information
Summary:Cytolytic T lymphocyte (CTL) responses were evaluated in humans immunized with recombinant human immunodeficiency virus type 1 (HIV) envelope glycoprotein gp160. Some vaccinees had gp160-specific CTLs that were shown by cloning to be CD4$^+$. Although induced by exogenous antigen, most gp160-specific CTL clones also recognized gp160 synthesized endogenously in target cells. These clones lysed autologous CD4$^+$ T lymphoblasts infected with HIV. Of particular interest were certain vaccine-induced clones that lysed HIV-infected cells, recognized gp160 from diverse HIV isolates, and did not participate in "innocent bystander" killing of noninfected CD4$^+$ T cells that had bound gp120.
Bibliography:SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-2
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0036-8075
1095-9203
DOI:10.1126/science.2190315